November 2012
On Inter Partes Reexamination, the Board Lacks Jurisdiction to Consider Arguments Based on References Determined by the Director as Not Raising a Substantial New Question of Patentability
[Appealed from Board]
For a Geographically Significant Mark, the Origin of the Designer Does Not Establish the Origin of the Goods
[Appealed from TTAB]
Dedication-Disclosure Rule Requires Disclosing to One of Ordinary Skill That Equivalent Is an Alternative to a Claim Limitation
[Appealed from W.D. Wis., Senior Judge Crabb]
Causal Nexus Test for Irreparable Harm Requires Plaintiff to Prove That Allegedly Infringing Features Affirmatively Drive Consumer Demand for the Accused Product
[Appealed from N.D. Cal., Judge Koh]
Adding Claim Limitations in Response to a Rejection of Closely Related Claims Without Explanation Creates Estoppel Barring Assertion of DOE
[Appealed from D. Del., Chief Judge Sleet]
SJ of Noninfringement of Global Paging System Patent Affirmed-in-Part and Reversed-in-Part
[Appealed from D. Md., Judge Williams]
Appeal from Board’s Improper Application of Means-Plus-Function Claim Construction Spurs Call for
En Banc Decision on Proper Standard of Review
No. 11-1476 (Fed. Cir. Oct. 23, 2012)
[Appealed from Board]
Abbreviations | |
ALJ | Administrative Law Judge |
ANDA | Abbreviated New Drug Application |
APA | Administrative Procedures Act |
APJ | Administrative Patent Judge |
Board | Board of Patent Appeals and Interferences |
Commissioner | Commissioner of Patents and Trademarks |
CIP | Continuation-in-Part |
DJ | Declaratory Judgment |
DOE | Doctrine of Equivalents |
FDA | Food and Drug Administration |
IDS | Information Disclosure Statement |
ITC | International Trade Commission |
JMOL | Judgment as a Matter of Law |
MPEP | Manual of Patent Examining Procedure |
NDA | New Drug Application |
PCT | Patent Cooperation Treaty |
PTO | United States Patent and Trademark Office |
SJ | Summary Judgment |
TTAB | Trademark Trial and Appeal Board |